Gamithromycin Impurity 1 - Request Quote
Gamithromycin Impurity 1
| SZ CAT No: | SZ-G034008 |
| CAS No | NA |
| Mol.F. | C29H56N2O9 |
| Mol.Wt. | 576.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gamithromycin Impurity 1 is chemically (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-11-(((2S,3S,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-1-oxa-7-azacyclopentadecan-15-one. Gamithromycin Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Gamithromycin Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gamithromycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Gamithromycin Impurity 1
Purchase Gamithromycin Impurity 1
Gamithromycin Impurity 1 suppliers
Gamithromycin Impurity 1 manufacturers
Gamithromycin Impurity 1 price
Order Gamithromycin Impurity 1
Enquire Gamithromycin Impurity 1
Gamithromycin Impurity 1 cost
Gamithromycin Impurity 1 Supplier
Gamithromycin Impurity 1 Distributor
Gamithromycin Impurity 1 for Method Validation
Gamithromycin Reference Standard
Gamithromycin Impurity 1 for ANDA Filing
Gamithromycin Impurity 1 for Forced Degradation Studies
Gamithromycin Impurity 1 Identification Standards
Gamithromycin Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


